Read by QxMD icon Read

perceval Valve

Giovanni A Chiariello, Emmanuel Villa, Antonio Messina, Margherita Dalla Tomba, Marco Cirillo, Federico Brunelli, Zean Mhagna, Giovanni Troise
No abstract text is available yet for this article.
February 27, 2018: Interactive Cardiovascular and Thoracic Surgery
Timothy Lee, Alexander J C Mittnacht, Shinobu Itagaki, Allan Stewart
Sutureless aortic valves are increasingly used for aortic valve replacement (AVR) with excellent outcomes. Implantation requires device expansion in a subannular position within the native aortic root. We report a patient with severe aortic stenosis who received a Perceval sutureless AVR (LivaNova, London, United Kingdom), resulting in a competent prosthesis with an absence of paravalvular leak and aortic regurgitation. However, this implantation resulted in the exacerbation of mitral regurgitation. The sutureless valve required explantation, and a traditional sutured valve was subsequently implanted, which returned the mitral regurgitation to baseline...
March 2018: Annals of Thoracic Surgery
Massimo Meco, Andrea Montisci, Antonio Miceli, Paolo Panisi, Francesco Donatelli, Silvia Cirri, Matteo Ferrarini, Antonio Lio, Mattia Glauber
BACKGROUND: Aortic stenosis is the most common valvular disease and has a dismal prognosis without surgical treatment. The aim of this meta-analysis was to quantitatively assess the comparative effectiveness of the Perceval (LivaNova) valve versus conventional aortic bioprostheses. METHODS AND RESULTS: A total of 6 comparative studies were identified, including 639 and 760 patients who underwent, respectively, aortic valve replacement with the Perceval sutureless valve (P group) and with a conventional bioprosthesis (C group)...
February 16, 2018: Journal of the American Heart Association
Alfredo Giuseppe Cerillo, Francesca Amoretti, Massimiliano Mariani, Emanuele Cigala, Michele Murzi, Tommaso Gasbarri, Marco Solinas, Dante Chiappino
BACKGROUND: Significant underexpansion or distortion of valved stents may be associated with altered leaflet function, leading to increased transprosthetic gradients and, possibly, early structural degeneration. We investigated the relationship between a computed tomography (CT) measure of the degree of oversizing and the early haemodynamic and clinical outcomes in patients undergoing aortic valve replacement with the Perceval sutureless aortic valve. METHODS: The degree of oversizing of the implanted prosthesis was calculated as the ratio between the patients' aortic annulus cross-sectional area (CSA) and the ex-vivo CSA of the implanted prosthesis in 151 perceval patients that had a preoperative cardiac CT...
February 2, 2018: Annals of Thoracic Surgery
Kathrin Freystaetter, Faruk Özalp
Quadricuspid aortic valve (QAV) is a rare occurrence, usually presenting with insufficiency rather than stenosis. We report a case of aortic valve replacement in a septuagenarian with a stenotic QAV, achieving a good result with a Sorin Perceval sutureless bioprosthesis. We emphasize the particular technique of implantation and possible pitfalls. Sutureless bioprosthetic valves present a feasible option for aortic valve replacement in patients with uncommon valve morphologies, aiming to reduce operative time...
January 24, 2018: Annals of Thoracic Surgery
Giovanni A Chiariello, Emmanuel Villa, Antonio Messina, Margherita Dalla Tomba, Marco Cirillo, Federico Brunelli, Zean Mhagna, Giovanni Troise
Because of its favourable haemodynamic characteristics and easy implantability, Mitroflow aortic valve bioprosthesis has been the valve of choice for many surgeons in patients with small aortic annulus. Disappointingly, early structural valve deterioration and high transvalvular gradients have been reported mostly in older patients with small prostheses. Reimplanting a new stented prosthesis sutured in a narrow and damaged annulus is technically challenging and demanding mainly in high-risk patients. Valve-in-valve transcatheter aortic valve implantation has been proposed as a viable option; however, it presents significant limitations because of residual high transprosthetic pressure gradients and risk of coronary occlusion...
January 11, 2018: Interactive Cardiovascular and Thoracic Surgery
G Santarpino, F Vogt
Despite the limited clinical relevance of thrombocytopenia after bioprosthetic aortic valve replacement (AVR), the postoperative depletion of platelet count continues to attract the attention of many authors. The development of thrombocytopenia has been evaluated either in patients receiving a sutureless bioprosthesis (1,2) or in those undergoing transcatheter aortic valve implantation, where cardiopulmonary bypass bears little or no relation to this phenomenon (3). Recently, Sánchez et al. (1) have published their findings on this topic, but their limited experience with the devices used makes their study of doubtful interest...
July 2017: Journal of Heart Valve Disease
Thijs Stoker, Ahmed Mashhour, Jerry Easo, Kay Kronberg, Jürgen Ennker, Alexander Weymann
We describe three patients with severe aortic regurgitation after aortic root replacement using the Medtronic Freestyle® bioprosthesis. In two cases, the indication was endocarditis. The third case showed rupture of the right coronary cusp. To achieve fewer complications, lower operative risk and save operative and cross-clamp times, implantation of a sutureless bioprosthesis in a valve-in-valve manner was performed. In two cases, a Perceval bioprosthesis and in the other case, a 3f-Enable bioprosthesis were used...
December 27, 2017: Annals of Thoracic Surgery
Antonino S Rubino, Carmelo Mignosa
BACKGROUND: Aim of this study was to assess the potential differences in respecting the principles of goal-directed perfusion between aortic valve replacement with sutureless vs conventional stented bioprostheses. METHODS: Data from 94 consecutive patients undergoing aortic valve replacement with Perceval sutureless valve, with or without concomitant CABG, were compared to a contemporary cohort of 116 patients receiving conventional stented bioprostheses. Propensity score matching was used to reduce selection bias...
December 14, 2017: Minerva Cardioangiologica
Elisabet Berastegui García, Maria Luisa Camara Rosell, Francisco Estevez Cid, Eladio Sanchez Dominguez, Remedios Rios Barrera, Fabrizio Sbraga, Julio Garcia Puente, Elena Rosello Diez, Gregorio Pablo Cuerpo Caballero, Juan Bustamante Munguira, Guillermo Reyes Copa, Marian Tena Pajuelo, Santiago Serrano Fiz, Jose Alfonso Buendía Miñano, Ivan García Martin, Jose Cuenca Castillo, Sergio Cánovas Lopez, Angel Gonzalez Pinto, Xavier Ruyra Baliarda
OBJECTIVES: The development of new percutaneous and surgical techniques has reduced the risk associated with aortic valve replacement procedures. We present the results of a Spanish register after initiating a programme for sutureless prostheses in moderate-high-risk patients. METHODS: This prospective multicentre study was carried out from November 2013 to November 2016. Data were obtained from 448 patients in whom a Perceval S prosthesis was implanted. RESULTS: The mean age was 79...
December 8, 2017: Interactive Cardiovascular and Thoracic Surgery
Elena Roselló-Díez, Gregorio Cuerpo, Francisco Estévez, C Christian Muñoz-Guijosa, Manel Tauron, José J Cuenca, Ángel Pinto, Josep María Padró
BACKGROUND: Surgical treatment of active prosthetic aortic valve endocarditis presents a challenge for cardiac surgeons because of tissue friability and destruction caused by infection. Sutureless prostheses, such as the Perceval S® (LivaNova, Saluggia, Italy), have emerged as an option among the different surgical approaches for these complicated cases. METHODS: This study presents data from nine patients who underwent aortic valve re-replacement with the Perceval S® due to active prosthetic aortic valve endocarditis, between January 2014 and August 2016...
December 9, 2017: Annals of Thoracic Surgery
Pascal M Dohmen
No abstract text is available yet for this article.
December 9, 2017: Annals of Thoracic Surgery
Lorenzo Di Bacco, Steffen Pfeiffer, Theodor J M Fischlein, Giuseppe Santarpino
We report a case of infective endocarditis on a Perceval S aortic valve bioprosthesis, and we describe a feasible and useful technique that can help remove the infected valve. These maneuvers consist of an "x-movement" reached with the aid of anatomical forceps. The risk of infective endocarditis in patients with prosthetic valves is a well-known phenomena in cardiac surgery, and it can represent a life-threatening event in many cases. According to guidelines, an emergency surgical intervention is required in case of high risk of embolization, vegetation superior than 1 cm or acute cardiac failure secondary to the acute valve dysfunction...
November 2017: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Alberto Repossini, Theodor Fischlein, Marco Solinas, Lorenzo DI Bacco, Bruno Passaretti, Herko Grubitzsch, Thierry Folliguet, Giuseppe Santarpino, Roberto DI Bartolomeo, François Laborde, Claudio Muneretto
BACKGROUND: Stentless aortic valves have been developed to overcome obstructive limitations associated with stented bioprostheses. A new concept of surgical sutureless (SU) bioprosthesis has been developed in the last decade. In this multi-institutional study we sought to compare hemodynamics of different bioprosthesis concept as transcatheter (TAVR), Livanova Perceval S sutureless valve and Freedom Solo Stentless (FS) valve in patients undergoing aortic valve replacement (sAVR). METHODS: From 2010 to 2016, 478 patients underwent sAVR with FS, 518 Perceval S and 367 patients underwent TAVR...
November 20, 2017: Minerva Cardioangiologica
Giuseppe Santarpino, Ferdinand Vogt, Steffen Pfeiffer, Angelo M Dell'Aquila, Jürgen Jessl, Federica Cuomo, Che von Wardenburg, Theodor Fischlein, Matthias Pauschinger, Johannes Schwab
BACKGROUND: Transcatheter aortic valve implantation (TAVI), especially via the transfemoral (TF) route, is increasingly performed in patients considered in the 'gray zone' between TAVI and surgery. However, the best treatment option in this patient population remains to be established. METHODS: Since 2010, a total of 923 patients underwent either TAVI (n = 538) or sutureless aortic valve replacement (AVR) (n = 385) at the authors' institutions. Among these patients, 79 treated with TF-TAVI were compared with 79 propensity score-matched patients who had undergone elective isolated AVR with the sutureless Perceval bioprosthesis...
May 2017: Journal of Heart Valve Disease
Mathieu Charles Blouin, Ismail Bouhout, Philippe Demers, Michel Carrier, Louis Perrault, Yoan Lamarche, Ismail El-Hamamsy, Denis Bouchard
BACKGROUND: Sutureless aortic valve replacement (AVR) is an emerging alternative to standard AVR in elderly and high-risk patients. This procedure is associated with a high rate of postoperative permanent pacemaker implantation (PPI). The study aim was to assess the impact on the rate of PPI of implanting the Perceval prosthesis without using balloon inflation. METHODS: A total of 159 patients who underwent sutureless AVR using the Perceval prosthesis was included...
May 2017: Journal of Heart Valve Disease
Antonino S Rubino, Fausto Biancari, Vincenzo Caruso, Vincenzo Lavanco, Fiorella Privitera, Ivana Rinaldi, Maria Sanfilippo, Giovanni Millan, Lucia V D'Urso, Sergio Castorina, Carmelo Mignosa
OBJECTIVES: The aim of this study was to evaluate the hemodynamic performance of a sutureless bioprosthesis under high workload at mid-term follow-up. METHODS: Thirty-two patients who underwent isolated aortic valve replacement with a Perceval sutureless bioprosthesis with a minimum follow-up of 1 year were enrolled in this study. S size prosthesis was deployed in 10 patients (31.3%), M size in 9 (28.1%), L size in 8 (25%) and XL size in 5 (15.6%). Effective orifice area (EOA), EOA index (EOAi), and transvalvular gradients were assessed at rest and during dobutamine stress echocardiography (DSE) a median of 19...
October 26, 2017: Echocardiography
Norman Mangner, David Holzhey, Martin Misfeld, Axel Linke
Valve-in-valve implantation is an alternative to reoperation for patients with degenerated bioprostheses. This case report presents a 75-year-old woman presenting with worsening dyspnoea according New York Heart Association (NYHA) Class III after she had received a Sorin Perceval® S sutureless valve due to severe aortic valve stenosis 5 years ago. Echocardiography revealed a degenerated Perceval valve with severe valvular aortic regurgitation and stenosis. After exclusion of acute infective endocarditis, an Edwards SAPIEN 3 was implanted leading to an immediate haemodynamic improvement...
October 10, 2017: Interactive Cardiovascular and Thoracic Surgery
Steffen Pfeiffer, Manuel Wilbring, Utz Kappert, Giuseppe Santarpino
Despite the excellent early performance of the Perceval sutureless valve, there have been recent reports of stent infolding, followed by paravalvular leak that was linked to valve oversizing. The purpose of this study was to review published reports by assessing photographic and radiological images. An in vitro study was also conducted with stent twisting that may occur during the collapse of the valve, termed 'stent entanglement', demonstrating consecutive successful valve collapse and implantation. This result has led us to hypothesize that infolding is due to a number of triggers, e...
July 26, 2017: Interactive Cardiovascular and Thoracic Surgery
Oliver J Liakopoulos, Stephen Gerfer, Simone Weider, Parwis Rahmanian, Mohamed Zeriouh, Kaveh Eghbalzadeh, Anton Sabashnikov, Yeong-Hoon Choi, Jens Wippermann, Thorsten Wahlers
BACKGROUND: Rapid deployment aortic valve replacement (RDAVR) has emerged as an attractive alternative to conventional aortic valve replacement. This single-center study directly compared two commercially available rapid deployment valves with regard to clinical outcomes, valve-related complications, and hemodynamic performance. METHODS: A total of consecutive 156 patients underwent RDAVR with the Intuity Elite (Edwards Lifesciences, Irvine, CA [Intuity group, n = 117] or the Perceval S (Sorin Group Italia Srl, Saluggia, Italy [Perceval group, n = 39]) between September 2012 and March 2016 at our institution...
January 2018: Annals of Thoracic Surgery
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"